A comprehensive approach to evaluate genetic abnormalities in multiple myeloma using optical genome mapping
Blood Cancer J
.
2024 May 3;14(1):78.
doi: 10.1038/s41408-024-01059-x.
Authors
Ying S Zou
1
,
Melanie Klausner
2
,
Jen Ghabrial
2
,
Victoria Stinnett
2
,
Patty Long
2
,
Laura Morsberger
2
,
Jaclyn B Murry
2
,
Katie Beierl
2
,
Christopher D Gocke
2
,
Rena R Xian
2
,
Kevin H Toomer
2
,
Jing Christine Ye
3
,
Robert Z Orlowski
3
4
,
Carol Ann Huff
5
,
Syed Abbas Ali
5
,
Philip H Imus
5
,
Christian B Gocke
5
,
Guilin Tang
6
Affiliations
1
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. yzou19@jhmi.edu.
2
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
3
Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
4
Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
5
Department of Oncology, The Sydney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
6
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Blvd, Houston, TX, 77030, USA.
PMID:
38702349
PMCID:
PMC11068911
DOI:
10.1038/s41408-024-01059-x
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
MeSH terms
Chromosome Aberrations
Chromosome Mapping
Humans
Multiple Myeloma* / diagnosis
Multiple Myeloma* / genetics
Grants and funding
K08 CA218893/CA/NCI NIH HHS/United States
R01 CA266612/CA/NCI NIH HHS/United States